Ricerca avanzata

Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2015 Marzo;57(1) > Panminerva Medica 2015 Marzo;57(1):1-13

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOPANMINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

 

Panminerva Medica 2015 Marzo;57(1):1-13

TARGETING CARDIAC ISSUES 

Bioresorbable scaffolds: focus on vascular response and long-term safety

Scalone G., Brugaletta S., Gomez O., Otsuki S., Sabate M.

Thorax Institute, Department of Cardiology, IDIBAPS: Institut d’Investigacions Biomediques Agust Pi i Sunyer (IDIBAPS), Hospital Clinic, Barcelona, Spain

Bioresorbable vascular scaffolds (BVS) are considered the fourth revolution in Interventional Cardiology, thus promising to address some of the pending issues with current-generation drug eluting stents (DES). Notably, most of the potential advantages of BVS over other current devices are due to a peculiar vascular response, called “vascular restoration therapy”. The emerging data from real-world expanded use registries suggest that BVS use is feasible in a wide variety of patients (from low- to high- risk), and lesions (from simplex to complex). However, few safety concerns with currently available BVS have arised from initial experiences all over the word. Data from ongoing large-scale randomized controlled trials will be able to demonstrate whether BVS improve patient early and long-term outcomes compared to best-in-class DES.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina